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Introduction and objective: The diagnosis of primary headaches is based on the
International Classiﬁcation of Headache Disorders (ICHD-3). Cluster headache (CH), a debil-
itating primary headache, is often misdiagnosed as migraine. In the absence of biological
markers, a new visual screening tool with images depicting pain could aid the correct diagnosis
of CH. The objective of the study is to test the tool on healthy participants and participants with
CH and migraine.
Methods: In phase 1, 6 images portraying people with pain were tested on 150 healthy
participants. The healthy participants were asked to rate the images as mild, moderate, severe
or excruciating pain. In phase 2, the images were further tested on 116 participants with
headache (16 participants with CH, 100 participants with migraine). The participants were
recruited prospectively from a tertiary headache center between February and May 2017. The
participants were asked to choose which image best illustrated their headache attacks.
Results: Phase 1 results showed that the images represent a range of headache pain
severities from mild to excruciating as rated by healthy participants. They rated two images
as excruciating, one image as severe, one image as moderate/severe, one image as moderate
and one image as mild. Phase 2 results showed that two-thirds of participants with CH (69%)
and half of the participants with migraine (52%) chose an image described as excruciating by
the healthy participants.
Conclusion: We developed a screening tool with six drawings depicting headache pain
severities from mild to excruciating as rated by the healthy participants. Although the images
did not differentiate between CH and migraine, the study indicated the potential of using
visual aids to assess headache severity.
Keywords: drawings, migraine, screening tool, diagnosis, visual, pictures, excruciating
Introduction
Headache disorders are the second leading cause of years lived with a disability
worldwide and interventions are urgently needed to reduce this burden through-
out the world.1 Cluster headache (CH), a severe primary headache,2 is often
referred as “suicide headache” because of the suicide rate among CH sufferers.3
Females with CH have described their cluster attacks as worse than childbirth.4
Although CH is not a rare condition, with a prevalence (1/1000)5 similar to the
prevalence of multiple sclerosis (0.9/1000)6 and Parkinson’s disease (1–3/
1000),7 it is not well known across both primary and secondary health care
settings and therefore often misdiagnosed.8 It is difﬁcult for health professionals
who are non-headache specialists to diagnose CH.8 The delays in diagnosis and
misdiagnosis (and subsequent mistreatment) occurs primarily because CH is
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confused with migraine.9,10 Migraine patients describe
the headache pain as moderate and severe, during an
attack they prefer to lie down in a dark room and avoid
physical activity.11 The intensity of migraine attack
develops over hours and can last up to three days.2,12
In contrast to migraine, the pain intensity of CH is
excruciating and is described as one of the most painful
conditions known to mankind.13 A CH attack starts
abruptly and usually ends within three hours, these are
associated with severe restlessness during the attacks.5
A correct diagnosis is important as CH and migraine are
managed differently.14 CH is treated with high ﬂow
oxygen, subcutaneous triptans as abortive medication
and verapamil as preventative treatment.15 Migraine
attacks are treated with oral triptans and tricyclic anti-
depressants, and b-blockers or antiepileptic medication
to prevent attacks from occurring.16
To date, there is only limited research evidence on
visual aids during headache17 or pain consultations.18–20
One study explored the usefulness of a visual diagnostic
aid for paediatric headaches.17 Drawings made by chil-
dren of their headache pain and associated symptoms
(eg vomiting, sensitivity to lights, visual aura) were
found to be useful to differentiate migraine from non-
migraine headache.17 Other studies found that laminated
photographs suggestive of pain could improve the com-
munication during pain consultations.18–20 To date, the
diagnosis of CH is based on clinical history2 and there
are no biological markers.21 In the absence of such
biomarkers, a new visual screening tool with images
representing different pain severities could aid health
professionals in assessing whether the patient suffers
from migraine or CH and decrease common misdiagno-
sis and delays in diagnosis.
There are two things that lay at the inceptions of this
study. Firstly, a small interview study conducted by FA
in our research team, in which CH and migraine patients
were interviewed and a set of images was used to
identity their symptoms and capture their verbal descrip-
tion of pain.22 Secondly, the ARTe Cluster Project, led
by Claudio Geraci, that collects and exhibits artistic
renditions of CH to raise awareness of the huge impact
the disease has on CH sufferers.23,24 We developed the
visual screening tool with two objectives in mind: (1) to
determine if six images depict are range of pain seve-
rities from mild to excruciating. This was achieved by
asking healthy participants to score the images; (2) to
test the visual tool on participants with CH and migraine
to determine which image best represented the pain
during their headache attacks.
Methods
Screening tool development
We decided to use a range of images that depict headache pain
in different ways, inspired on real life pictures and images
frequently used on CH websites.24 The same person sketched
six drawings as we wanted all the images to have similar
characteristics (color saturation and chromatic range) in order
to avoid the inﬂuence of color on attentional bias.25 All images
were printed in black-and-white on the same size.
Phase 1
The screening tool was tested on 150 healthy participants
to determine if the images depict a range of pain severities.
These were people without a history of headaches or
chronic pain conditions. The healthy participants were
asked to rate each image as showing mild, moderate,
severe or excruciating pain. They had the option to choose
multiple answers or not to answer (Figure 1).
Phase 2
The screening tool was further tested on 116 participants with
headache (16 participants with CH, 100 participants with
migraine). Participants received a prior diagnosis of CH or
migraine (control group) based on the ICHD-3b26 criteria
before they were enrolled in the study. The participants were
recruited prospectively from a tertiary headache center
between February-May 2017. The participants were asked to
choose which image best illustrated their headache attacks
(Figure 2).
Ethics
This study received ethical approvals from the local University
of Hull Research Ethics Committee (1613/27.09.2016) and
from the UK Health and Social Care Research Ethics
Committee (HSC REC) (16/NI/0269). Written informed con-
sent was obtained from all participants before taking part in the
study.
Results
Phase 1
One hundred and ﬁfty healthy participants were included
in the study. Our ﬁndings are that the participants agreed
that the six images in the screening tool are depicting a
range of pain severities from mild to excruciating (Table 1
and Figure 3). The participants rated image 1 (n=131/150,
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87%) and 5 (n=93/150; 63%) as “excruciating”. Twenty-
one percent (n=32/150) of the participants chose not to
rate image 5. Therefore, image 1 seems to be more repre-
sentative for expressing an excruciating level of pain.
Image 2 was rated as either moderate (n=60/150; 40%)
or severe (n=59/150; 39%). The participants rated image 3
(n=93/150; 62%), image 4 (n=88/150; 58%) and image 6
(n=129/150; 86%) as showing severe, moderate and mild
level of pain respectively.
Phase 2
One hundred and sixteen participants were included: 100
participants with migraine (93 participants with chronic
migraine; seven participants with episodic migraine) and 16
participants with CH (nine participants with chronic CH;
seven participants with episodic CH). Eighty-six percent
(86%) of the participants with migraine are females and
14% males with a mean age of 44 (SD 11) (females n=86/
100; males n=14/100). Nineteen percent (19%) of
Please answer the following questions:
(There is no right or wrong answer. Please rate all the images. You can choose more than
Which images/s, in your opinion, represent/s:
1. excruciating pain?
severe pain?
moderate pain?
mild pain?
Image 1
Image 3 Image 4
Image 2
Image 5 Image 6
2.
3.
4.
one image for each answer but you cannot choose the same image for more than one answer)
Figure 1 Visual tool tested on healthy participants.
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participants with CH were females and 81% males with a
mean age of 48 (SD 14) (females n=3/16; males n=13/16)
(Table 2).
Two-thirds of the participants with CH (n=11/16;
69%) and half of the participants with migraine (n=52/
100; 52%) chose image 1 as being the most
Participant no
Male/Female
Age
Image 1 Image 2
Image 3 Image 4
Image 5 Image 6
Diagnosis: Migraine/Cluster Headache; Episodic/Chronic
Please choose one image that best illustrates the most severe headache you have experienced:
Figure 2 Visual tool tested on participants with cluster headache and migraine.
Table 1 Image rating according to severity
Image no. Severity rating (number of participants)
Mild Moderate Severe Excruciating No rating
Image 1 0 0 1 131 18
Image 2 9 60 59 4 18
Image 3 2 18 93 25 12
Image 4 26 88 24 4 8
Image 5 0 3 22 93 32
Image 6 129 15 1 0 5
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representative for their headache attacks (Figures 4 and
5 and Table 3). Image 2 or image 3 are representative
for the attacks of 41% (n=41/100) participants with
migraine (and 25% participants with CH; n=4/16).
Image 4 was chosen by 4% (n=4/100) of participants
with migraine and 6% (n=1/16) of participants with
CH. Image 5 and 6 are representative for the attacks
of 3% (n=3/100) of participants with migraine whilst
no participants with CH have chosen these two images.
Discussion
Healthy participants determined that the six images in the
new screening tool portray a range of pain severities from
mild to excruciating. Our ﬁndings indicate that two-thirds
of the participants with CH chose image 1, rated as excru-
ciating by healthy participants to represent their attacks.
This could imply that participants with CH regard their
pain as “excruciating”, which is consistent with the current
literature.4,27 According to the International Classiﬁcation
of Headache Disorders, migraine is described as moderate/
Table 2 Demographics of the study population
Variable Migraine Cluster headache
Number of participants 100 16
Number of female/male 86/14 3/13
Number of episodic/chronic 93/7 7/9
Gender ratio (female/male) 6.14 0.23
Age in years: mean (SD) 44 (11) 48 (14)
1%
99%
Mild
Moderate
Severe
Excruciating
7%
45%
45%
3%
Mild
Moderate
Severe
Excruciating
2%
13%
67%
18%
Mild
Moderate
Severe
Excruciating
18%
62%
17%
3%
Mild
Moderate
Severe
Excruciating
2%
19%
79%
Mild
Moderate
Severe
Excruciating
89%
10%
1%
Mild
Moderate
Severe
Excruciating
Figure 3 Image selection by healthy participants.
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severe pain whereas CH as severe/very severe pain2 of
excruciating quality.4 Furthermore, the intensity of pain is
regarded as a key feature in differentiating CH from
migraine.2 CH is described by female sufferers as worse
than childbirth4 or as the worst pain one can expeerince.13
Half of the participants with migraine in this study (52%)
chose image 1 as representing their attacks. This could
indicate that the pain perceived by half of the migraine
participants could be interpreted as “excruciating”.
However, this was suggested from the image chosen,
which was rated by healthy participants. A previous sur-
vey study reported on the presence of “excruciating pain”
in CH and other primary headaches.28 The “excruciating
pain” had a low speciﬁcity (34%) in detecting CH which
suggests that the participants with non-CH in this study
(migraine and tension type headache) chose “excruciating
pain” to describe their attacks.28 However, the question
addressed to patients “Is the pain severe and/or unbear-
able?” was interpreted by the authors as “excruciating
pain”.28
Image 5 was rated in the same way as image 1 by
healthy participants although none of the participants with
CH have chosen this image to describe their attacks. Image
5 not rated by 20% of the healthy participants. Although
the reason was not captured, we could speculate that the
level of pain depicted by image 5 is not clear to both
healthy participants and participants with CH. Although
migraine is described as moderate/severe pain in the
literature,2 4% of participants with migraine chose image
4 rated as moderate by healthy participants. None of the
six images in this study were able to differentiate between
CH and migraine.
Strengths and limitations
This is the ﬁrst study to explore the use of visual aids to
assess and facilitate the diagnosis of primary headaches.
The main limitation is that the ratio between participants
with CH versus those with migraine (16 vs 100). However,
this ratio reﬂects the prevalence of migraine (12%)29 ver-
sus CH (0.1%).5 Although the images in this study did not
differentiate between CH and migraine, the study did
indicate the potential of using visual aids to depict head-
ache severity.
Future directions
The aim of future research is to establish whether the
ﬁndings of this study will be replicated in a larger study
with a bigger population which is currently being
undertaken.30 The study is testing a screening tool for
CH which includes images depicting pain, verbal descrip-
tors of pain and key questions able to differentiate between
CH and migraine.30 A comparison of the characteristics of
these two conditions will be performed, aiming to estab-
lish the clinical features that best differentiate between the
two. Future studies could explore whether images depict-
ing headache pain could be a useful diagnostic aid in
patients with language barriers.
Cluster headache
Image 1
6%
19%
6%
69%
Image 2
Image 3
Image 4
Image 5
Image 6
Figure 4 Image selection by participants with cluster headache.
Migraine
Image 1
1%
2%
21%
4%
20%
52%
Image 2
Image 3
Image 4
Image 5
Image 6
Figure 5 Image selection by participants with migraine.
Table 3 Image selection classiﬁed by diagnosis
Image Migraine
(number of patients)
Cluster headache
(number of patients)
Image 1 52 11
Image 2 20 1
Image 3 21 3
Image 4 4 1
Image 5 2 0
Image 6 1 0
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Conclusion
Healthy participants rated the six drawings in a new
screening tool as showing a rage of pain severities from
mild to excruciating. Although both CH and migraine
participants chose similar images to describe their head-
ache attacks, the study indicated the potential of using
images to depict headache severity.
Acknowledgment
We would like to thank Claudio Geraci for his work on the
ARTe Cluster Project which inspired the research team to
explore the potential of using images in screening for primary
headaches.
Disclosure
FA served as an advisory board member and received honor-
aria fromAllergan, Novartis, TEVA, Electrocore and Eneura,
which he donated to charitable organisations (Migraine
Trust, BASH and ADMA). The other authors report no
conﬂicts of interest in this work.
References
1. Saylor D, Steiner TJ. The global burden of headache. Semin Neurol.
2018;38(2):182–190. doi:10.1055/s-0038-1646946
2. ICHD-3. Headache Classiﬁcation Committee of the International
Headache Society (IHS) The International Classiﬁcation of
Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.
doi:10.1177/0333102417738202
3. Robbins MS. The psychiatric comorbidities of cluster headache. Curr
Pain Headache Rep. 2013;17(2):313. doi:10.1007/s11916-012-0313-8
4. May A, Schwedt TJ, Magis D, Pozo-Rosich P, Evers S, Wang S-J.
Cluster headache. Nat Rev Dis Primers. 2018;4:18006. doi:10.1038/
nrdp.2018.6
5. Wei DY-T, Yuan Ong JJ, Goadsby PJ. Cluster headache: epidemiol-
ogy, pathophysiology, clinical features, and diagnosis. Ann Indian
Acad Neurol. 2018;21(Suppl 1):3–8. doi:10.4103/aian.AIAN_349_17
6. Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple
sclerosis. Rev Neurol (Paris). 2016;172(1):3–13. doi:10.1016/j.
neurol.2015.10.006
7. Elbaz A, Carcaillon L, Kab S, Moisan F. Epidemiology of
Parkinson’s disease. Rev Neurol (Paris). 2016;172(1):14–26.
doi:10.1016/j.neurol.2015.09.012
8. Buture A, Ahmed F, Dikomitis L, Boland JW. Systematic literature
review on the delays in the diagnosis and misdiagnosis of cluster head-
ache. Neurol Sci. 2019;40(1):25–39. doi:10.1007/s10072-018-3598-5
9. Van Alboom E, Louis P, Van Zandijcke M, Crevits L, Vakaet A,
Paemeleire K. Diagnostic and therapeutic trajectory of cluster head-
ache patients in Flanders. Acta Neurol Belg. 2009;109(1):10–17.
10. Sanchez Del Rio M, Leira R, Pozo-Rosich P, Laínez JM, Alvarez R,
Pascual J. Errors in recognition and management are still frequent in
patients with cluster headache. Eur Neurol. 2014;72(3–4):209–212.
doi:10.1159/000362517
11. Gupta R, Bhatia MS. Comparison of clinical characteristics of
migraine and tension type headache. Indian J Psychiatry. 2011;53
(2):134–139. doi:10.4103/0019-5545.82538
12. Kim BK, Chung YK, Kim J-M, Lee K-S, Chu MK. Prevalence,
clinical characteristics and disability of migraine and probable
migraine: a nationwide population-based survey in Korea.
Cephalalgia. 2013;33(13):1106–1116. doi:10.1177/0333102413484
990
13. Bahra A, May A, Goadsby PJ. Cluster headache: a prospective
clinical study with diagnostic implications. Neurology. 2002;58
(3):354–361. doi:10.1212/wnl.58.3.354
14. Gooriah R, Buture A, Ahmed F. Evidence-based treatments for cluster
headache. Ther Clin Risk Manag. 2015;11:1687–1696. doi:10.2147/
TCRM.S94193
15. Schurks M, Kurth T, de Jesus J, Jonjic M, Rosskopf D, Diener H-C.
Cluster headache: clinical presentation, lifestyle features, and medical
treatment. Headache. 2006;46(8):1246–1254. doi:10.1111/j.1526-
4610.2006.00534.x
16. Sun-Edelstein C, Rapoport AM. Update on the Pharmacological
Treatment of Chronic Migraine. Curr Pain Headache Rep. 2016;20
(1):6. doi:10.1007/s11916-015-0533-9
17. Stafstrom CE, Rostasy K, Minster A. The usefulness of children’s
drawings in the diagnosis of headache. Pediatrics. 2002;109(3):460–
472. doi:10.1542/peds.109.3.460
18. Padﬁeld D, Omand H, Semino E, de C Williams AC, Zakrzewska
JM. Images as catalysts for meaning-making in medical pain encoun-
ters: a multidisciplinary analysis. Med Humanit. 2018;44:74–81.
doi:10.1136/medhum-2017-011415
19. Padﬁeld D, Janmohamed F, Zakrzewska JM, Pither C, Hurwitz B. A
slippery surface … can photographic images of pain improve com-
munication in pain consultations? Int J Surg. 2010;8(2):144–150.
doi:10.1016/j.ijsu.2009.11.014
20. Ashton-James CE, Dekker PH, Addai-Davis J, et al. Can images of
pain enhance patient–clinician rapport in pain consultations? Br J
Pain. 2017;11(3):144–152. doi:10.1177/2049463717717125
21. Buture A, Boland JW, Dikomitis L, Ahmed F. Update on the
pathophysiology of cluster headache: imaging and neuropeptide
studies. J Pain Res. 2019;12:269–281. doi:10.2147/JPR.S17
5312
22. Khan I, Ahmed F. Visual images can prove to be an import tool to aid
in the diagnosis of cluster headache. J Headache Pain. 2014;15
(Suppl1:I1–I1. doi:10.1186/1129-2377-15-S1-I1
23. Rossi P, Geraci C, Navarro FM. ARTe Cluster project. Cluster
Headache Pain Inspiration. 2014;15(Suppl 1):C55.
24. Al. Ce.Cluster. Available from: http://alcecluster.cefalea.it/. Accessed
February 27, 2019
25. Bekhtereva V, Müller MM. Bringing color to emotion: the inﬂuence of
color on attentional bias to brieﬂy presented emotional images. Cogn
Affect Behav Neurosci. 2017;17:1028–1047. doi:10.3758/s13415-017-
0530-z
26. ICHD3beta. The international classiﬁcation of headache disorders:
3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.
doi:10.1177/0333102413485658
27. Lambru G, Matharu MS. Trigeminal autonomic cephalalgias: a
review of recent diagnostic, therapeutic and pathophysiological
developments. Ann Indian Acad Neurol. 2012;15(Suppl 1):51–61.
doi:10.4103/0972-2327.100007
28. Torelli P, Beghi E, Manzoni GC. Validation of a questionnaire for the
detection of cluster headache. Headache. 2005;45(6):644–652.
doi:10.1111/j.1526-4610.2005.05131.x
29. Yeh WZ, Blizzard L, Taylor BV. What is the actual prevalence of
migraine? Brain Behav. 2018;8(6):e00950. doi:10.1002/brb3.2018.8.
issue-6
30. Buture A, Dikomitis L, Boland JW, Ahmed F. Images depicting pain-
a screening tool for cluster headache. Cephalalgia. 2018;38(1S):114.
Dovepress Buture et al
Journal of Multidisciplinary Healthcare 2019:12 submit your manuscript | www.dovepress.com
DovePress
697
 
Jo
ur
na
l o
f M
ul
tid
isc
ip
lin
ar
y 
He
al
th
ca
re
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
15
0.
23
7.
20
0.
53
 o
n 
31
-A
ug
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Journal of Multidisciplinary Healthcare Dovepress
Publish your work in this journal
The Journal of Multidisciplinary Healthcare is an international, peer-
reviewed open-access journal that aims to represent and publish
research in healthcare areas delivered by practitioners of different
disciplines. This includes studies and reviews conducted by multi-
disciplinary teams as well as research which evaluates the results or
conduct of such teams or healthcare processes in general. The journal
covers a very wide range of areas and welcomes submissions from
practitioners at all levels, from all over the world. The manuscript
management system is completely online and includes a very quick and
fair peer-review system. Visit http://www.dovepress.com/testimonials.
php to read real quotes from published authors.
Submit your manuscript here: https://www.dovepress.com/journal-of-inﬂammation-research-journal
Buture et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Journal of Multidisciplinary Healthcare 2019:12698
 
Jo
ur
na
l o
f M
ul
tid
isc
ip
lin
ar
y 
He
al
th
ca
re
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
15
0.
23
7.
20
0.
53
 o
n 
31
-A
ug
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
